By Helena Smolak
Royal Philips is scheduled to report results for the first quarter on Tuesday. Here is what you need to know.
SALES FORECAST: The Dutch health-technology company is expected to post 4.02 billion euros ($4.54 billion) in first-quarter sales, according to a company-compiled consensus, against 4.14 billion euros in the same prior-year period.
ADJUSTED EBITA FORECAST: Philips's adjusted earnings before interest, taxes and amortization is expected at 309 million euros by consensus for the quarter compared to 388 million euros last year.
NET INCOME FORECAST: Analysts estimate that the Amsterdam-listed group will report 19 million euros in first-quarter net income attributable to shareholders--compared with a net loss of 999 million euros in the first quarter of 2024.
As of Friday's market close in Europe, the stock fell 6.9% since the start of 2025.
WHAT TO WATCH
--China: Royal Philips will likely see a sales decline in China in the quarter due to uncertain market conditions on subdued demand for both consumer and health systems in the country, Jefferies and Morgan Stanley analysts said in a note. ING analysts expect a slow start to the year as Philips guided that growth will be back-end loaded.
--Tariffs: Morgan Stanley analysts see higher risks on potential tariff exposure for products in Royal Philips's consumer categories such as electric toothbrushes and razors compared with other of its medtech categories.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
May 02, 2025 12:53 ET (16:53 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。